Joint Formulary & PAD

Beclometasone with formoterol (Fostair) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

PAD Profile

ChemicalSubstance :
Beclometasone with formoterol (Fostair)
Indication :
Asthma
Group Name :
ICS LABA
Keywords :
ICS LABAs, ICS/LABAs, inhaled corticosteroids, long-acting beta agonists, respiratory, asthmatics, MART action plans, maintenance and reliever therapy
Brand Names Include :
Fostair
Important Information :

Fostair 100/6, 200/6 not licensed in under 18 years. Not licensed for AIR.

Not for initiation in new patients. Proxor device is much less expensive.

Further information is being sought with regard to Proxor / Fostair bioequivalence. To be reviewed in Jul/Aug 2025.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
9

Other Indications

Below are listed other indications that Beclometasone with formoterol (Fostair) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (0)

  • No records returned.